Management of human ulcerative colitis by saturex™: A randomized controlled trial

International Journal of Pharmacology

Volumn 7, Issue 4, 2011, Pages 516-521

  Rastegarpanah, Mansoor ^a,b,c   Omidzohour, Naghmeh ^a,b,c,d   Vahedi, Homayoon ^c   Malekzadeh, Reza ^c   Hashemian, Farshad ^d   Safarnavadeh, Tahereh ^c   Abdollahi, Mohammad ^a,b,c,d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Oxidative stress; Randomized controlled trial; Satureja khuzestanica; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; HEMOGLOBIN; HERBACEOUS AGENT; MESALAZINE; PLACEBO; SATUREX; STEROID; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BLOODY DIARRHEA; BODY TEMPERATURE; CLINICAL ARTICLE; COLITIS; CONTROLLED STUDY; DEFECATION; DISEASE ACTIVITY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG FEVER; DRUG MECHANISM; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEMATOCHEZIA; HUMAN; MALE; OXIDATIVE STRESS; PROCTITIS; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; REMISSION; SATUREJA KHUZESTANICA; SAVORY; SCORING SYSTEM; ULCERATIVE COLITIS;

EID: 79959435798     PISSN: 18117775     EISSN: 18125700     Source Type: Journal    
DOI: 10.3923/ijp.2011.516.521     Document Type: Article

References (42)

1. Abdolghaffari, A.H., A. Baghaei, F. Moayer, H. Esmaily and M. Baeeri et al, 2010. On the benefit of Teucrium in murine colitis through improvement of toxic inflammatory mediators. Hum. Exp. Toxicol., 29: 287-295.
2. Abdollahi, M., A. Salehnia, S.H.R. Mortazavi, M. Ebrahimi, and A. Shafiee, et al, 2003. Antioxidant, antidiabetic, antihyperlipidemic, reproduction stimulatory properties and safety of Satureja Khuzestanica essential oil as in rat in vivo: A toxico pharmacological study. Med. Sci. Monit, 9: 331-335.
3. Amini-Shirazi, N, A. Hoseini, A. Ranjbar, A. Mohammadirad, N. Yasa, and M. Abdollahi, 2009. Inhibition of tumor necrosis factor and nitrosative/oxidative stresses by ziziphora clinopoides (Kahlioti); A molecular mechanism of protection against dextran sodium sulfate-induced colitis in mice. Toxicol. Mech. Methods., 19: 183-189.
4. Ashtaral-Nakhai, L., A. Mohammadirad, N. Yasa, B. Minaie and S. Nikfar et al, 2007. Benefits of Zataria multiflora Boiss in experimental model of mouse inflammatory bowel disease. Evid. Based Complement. Alternat. Med., 4: 43-50.
5. ®), a novel drug with potent anti-toxic stress potential in rat inflammatory bowel disease and comparison with dexamethasone and infliximab. Ind. J. Biochem. Biophys., 47: 219-226.
6. Basiri, S., H. Esmaily, S. Vosough-Ghanbari, A. Mohammadirad, N. Yasa, and M. Abdollahi, 2007. Improvement by Satureja khuzestanica essential oil of malathion-induced red blood cells acetylcholinesterase inhibition and altered hepatic mitochondrial glycogen phosphorylase and phosphoenolpyruvate carboxykinase activities. Pestic. Biochem. Physiol, 89: 124-129.
7. Ebrahimi, F., H. Esmaily, M. Baeeri, A. Mohammadirad, S. Fallah and M. Abdollahi, 2008. Molecular evidences on the benefit of N-acetylcysteine in experimental colitis. Cent. Eur. J. Biol. 3: 135-142.
8. Elahi, B., S. Nikfar, S. Derakhshani, M. Vafaie and M. Abdollahi, 2008. On the benefit of probiotics in the management of pouchitis in patients underwent ileal pouch anal anastomosis: A meta-analysis of controlled clinical trials. Dig. Dis. Sci., 53: 1278-1284.
9. Elahi, B., S. Nikfar, S. Derakhshani, M. Vafaie and M. Abdollahi, 2009. Benefit of antibiotic therapy on pouchitis after ileal pouch anal anastomosis: A systematic review and meta-analysis of clinical trials. Cent. Eur. J. Med., 4: 164-170.
10. Esmaily, H., A. Hosseini-Tabatabaei, R. Rahimian, R. Khorasani and M. Baeeri et al, 2009. On the benefits of silymarine in murine colitis by improving balance of destructive cytokines and reduction of toxic stress in the bowel cells. Cent. Eur. J. Biol, 4: 204-213.
11. Ghafari, H., N. Yasa, A. Mohammadirad, G. Dehghan and M.J. Zamani et al, 2006. Protection by Ziziphora clinopoides of acetic acid-induced toxic bowel inflammation through reduction of cellular lipid peroxidation and myeloperoxidase activity. Hum. Exp. Toxicol, 25: 325-332.
12. Ghazanfari, G., B. Minaie, N. Yasa, L. AshtaralNakhai and A. Mohammadirad et al, 2006. Biochemical and histopathological evidences for beneficial effects of Satureja khuzestanica jamzad essential oil on the mouse model of inflammatory bowel diseases. Toxicol. Mech. Methods, 16: 365-372.
13. Haeri, S., B. Minaie, G. Amin, S. Nikfar and R. Khorasani, et al. 2006. Effect of Satureja khuzestanica essential oil on male rat fertility. Fitoterapia, 77: 495-499.
14. Hasani-Ranjbar, S., B. Larijani and M. Abdollahi, 2009. A systematic review of the potential herbal sources of future drugs effective in oxidant-related diseases. Inflamm. Allergy Drug Targets, 8: 2-10.
15. Hosseini-Tabatabaei, A. and M. Abdollahi, 2008. Potassium channel openers and improvement of toxic stress: Do they have role in the management of inflammatory bowel disease. Inflamm. Allergy Drug Targets, 7: 129-135.
16. Khoshakhlagh, P., M. Bahrololoumi-Shapourabadi, A. Mohammadirad, L. Ashtaral-Nakhai, B. Minaie and M. Abdollahi, 2007. Beneficial effect of phosphodiesterase-5 inhibitor in experimental inflammatory bowel disease; molecular evidence for involvement of oxidative stress. Toxicol. Mech. Methods, 17: 281-288.
17. Momtaz, S., and M. Abdollahi, 2008. A systematic review of the biological activities of Satureja L. species. Pharmacology online, 2: 34-54.
18. Momtaz, S. and M. Abdollahi, 2010. An update on pharmacology of Satureja species; From antioxidant, antimicrobial, antidiabetes and anti-hyperlipidemic to reproductive stimulation. Int. J. Pharmacol, 6: 346-353.
19. Nikfar, S., R. Rahimi, A. Rezaie, and M. Abdollahi, 2009. A Meta-Analysis of the efficacy of sulfasalazine in comparison with 5-aminosalicylates in the induction of improvement and maintenance of remission in patients with ulcerative colitis. Dig. Dis. Sci., 54: 1157-1170.
20. Nikfar, S., H. Mirfazaelian and M. Abdollahi, 2010a. Efficacy and tolerability of immunoregulators and antibiotics in fistulizing Crohn's disease: A systematic review and meta-analysis of placebo-controlled trials. Curr. Pharm. Des., 16: 3684-3698.
21. Nikfar, S., M. Darvish-Damavandi and M. Abdollahi, 2010b. A review and meta-analysis of the efficacy of antibiotics and probiotics in management of pouchitis. Int. I. Pharmacol., 6: 826-835.
22. Nikfar, S., S. Ehteshami-Ashar, R. Rahimi and M. Abdollahi, 2010c. Systematic review and meta-analysis of the efficacy and tolerability of nicotine preparations in active ulcerative colitis. Clin. Ther., 32: 2304-2315.
23. Rahimi, R., S. Nikfar, A. Rezaie and M. Abdollahi, 2006. A meta-analysis of broad spectrum antibiotic therapy in patients with active Crohn's disease. Clin. Ther. 28: 1983-1988.
24. Rahimi, R., S. Nikfar and M. Abdollahi, 2007a. Do anti-tumor necrosis factors induce response and remission in patients with acute refractory Crohn's disease: A systematic meta-analysis of controlled clinical trials. Biomed. Pharmacother., 61: 75-80.
25. Rahimi, R., S. Nikfar and M. Abdollahi, 2007b. Meta-analysis technique confirms the effectiveness of anti-TNF-a in the management of active ulcerative colitis when administered in combination with corticosteroids. Med. Sci. Momt, 13: 13-18.
26. Rahimi, R., S. Nikfar, A. Rezaie and M. Abdollahi, 2007c. A meta-analysis of antibiotic therapy for active ulcerative colitis. Dig. Dis. Sci., 52: 2920-2925.
27. Rahimi, R., S. Nikfar and A. Rezaie, 2008a. A meta-analysis of the benefit of probiotics in maintaining remission of human ulcerative colitis: Evidence for prevention of disease relapse and maintenance of remission. Arch. Med. Sci., 4: 185-190.
28. Rahimi, R, S. Nikfar, A. Rezaie and M. Abdollahi, 2008b. Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: A meta-analysis. Reprod. Toxicol., 25: 271-275.
29. Rahimi, R, S. Nikfar, F. Rahimi, B. Elahi, S. Derakhsham, M. Vafaie and M. Abdollahi, 2008c. A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn's disease. Dig. Dis. Sci., 53: 2524-2531.
30. Rahimi, R., S. Mozaffan and M. Abdollahi, 2009a. On the use of herbal medicines in management of inflammatory bowel diseases: A systematic review of animal andhumanstudies. Dig. Dis. Sci., 54: 471-480.
31. Rahimi, R, S. Nikfar, A. Rezaie and M. Abdollahi, 2009b. Comparison of mesalazine and balsalazide in induction and maintenance of remission in patients with ulcerative colitis: A meta-analysis. Dig. Dis. Sci., 54: 712-721.
32. Rahimi, R., M.R. Shams-Ardekam and M. Abdollahi, 2010. A review of the efficacy of traditional Iranian medicine for inflammatory bowel disease. World I. Gastroenterol., 16: 4504-4514.
33. Rezaie, A., F. Ghorbani, A. Eshghtork, M.I. Zamani and G. Dehghan et al, 2006. Alterations in salivary antioxidants, nitric oxide and transforming growth factor-al in relation to disease activity in Crohn's disease patients. Ann. N.Y. Acad. Sci., 1091: 110-122.
34. Rezaie, A., R.D. Parker and M. Abdollahi, 2007a. Oxidative stress and pathogenesis of inflammatory bowel disease: An epiphenomenon or the cause. Dig. Dis. Sci., 52: 2015-2021.
35. Rezaie, A., S. Khalaj, M. Shabihkhani, S. Nikfar, M.I. Zamani, A. Mohammadirad, N.E. Daryani 2007b. Study on the correlations among disease activity index and salivary transforming growth factor-al and nitric oxide in ulcerative colitis patients. Ann. N.Y. Acad. Sci., 1095: 305-314.
36. Rezvanfar, M.A., R.A. Sadrkhanlou, A. Ahmadi, H. Shojaei-Sadee and M.A. Rezvanfar et al, 2008. Protection of cyclophosphamide-induced toxicity in reproductive tract histology, sperm characteristics and DNA damage by an herbal source; evidence for role of free-radical toxic stress. Hum. Exp. Toxicol, 27: 901-910.
37. Rezvanfar, M.A., A.A. Farshid, R.A. Sadrkhanlou, A. Ahmadi, M.A. Rezvanfar, A. Salehnia and M. Abdollahi, 2010. Benefit of Satureja khuzestanica in subchronically rat model of cyclophosphamide-induced hemorrhagic cystitis. Exp. Toxicol. Pathol, 62: 323-330.
38. Saadat, M., S. Pournourmohammadi, M. Donyavi, R. Khorasani, G. Amin, A.N. Salehnia and M. Abdollahi, 2004. Alteration of rat hepatic glycogen phosphorylase and phosphoenolpyruvate carboxykinase activities by Satureja khuzestanica lamzad essential oil. I. Pharmacy Pharm. Sci., 7: 327-331.
39. Salari, P. and M. Abdollahi, 2009. Current opinion in the pharmaceutical management of irritable and inflammatory bowel diseases: Role of ATP. Rec. Pat. Endoc. Metab. Immune Drug Disc, 3: 69-75.
40. Salari-Sharif, P. and M. Abdollahi, 2010. Phosphodiesterase 4 inhibitors in inflammatory bowel disease: A comprehensive review. Curr. Pharm. Des., 16: 3661-3667.
41. 1 and chlorhexidine in advanced periodontitis. Arch. Med. Sci., 7: 154-160.
42. Vosough-Ghanbari, S., R. Rahimi, S. Kharabaf, S. Zeinali and A. Mohammadirad et al, 2010. Effects of Satureja khuzestanica on serum glucose, lipids and markers of oxidative stress in patients with type 2 diabetes mellitus: A double-blind randomized controlled trial. Evrd. Based complement. Alternat. Mad. 7: 465-470.